Approval · Notice of Compliance 27533 · 2022
STALEVO: Notice of Compliance 27533
Issued February 4, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27533
- Date
- February 4, 2022
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug substance-manufacturing site for carbidopa (with EDQM CEP).
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| STALEVO | Not yet assigned | — |